[Discussion] LC-MS is doing more work than we give it credit for
LC-MS is doing more work than we give it credit for, and I am aware this is a minority view on this board.
Why two honest labs report different numbers on the same vial.
Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.
Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.
A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.
The system suitability argument, since it comes up whenever somebody posts a number without one.
Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.
None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.
Reading a trace posted here, in the order I actually look at things.
Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.
Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.
If two or three other people have done the same thing we might actually learn something. Alone it is an anecdote.
best — the order this archive was captured in
Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.
reproducibility beats resolution if you only get one of them
area percent is relative to what the detector saw and nothing else
[removed by moderator]
Same method at both labs, or two different gradients?
baseline choice is a decision, not a measurement
Do you have the mass, or only the UV trace?
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
retention time alone is not identity
two labs, two gradients, two honest answers
Sent the same vial to PeptideMeter and VendorInvestigate. 98.1% against a claimed 97.5%. The difference was the gradient, not the material.
System suitability — repeat injections, tailing factor, plate count, RSD on area — is what tells you the instrument was fit for the measurement that day. Without it, the purity figure is unanchored.
Method questions stay here; supplier claims go to c/vendorvetting with a document attached.
the column has a history and it shows in the peak shape
Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.
Carryover from a previous high-concentration injection looks exactly like a small impurity.
This is the whole methodological point of the board in one line.
A shoulder that does not baseline-resolve cannot be quantified honestly. You can report it as an unresolved shoulder, which is useful information, or you can develop the method until it resolves.
Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.
Area percent is the integrated area of your peak over the total integrated area at one wavelength on one gradient. Change any of those and the number changes without the sample changing.
What wavelength, and what was the gradient?
Agreed. Two analysts, one trace, two integration choices, and a spread that has nothing to do with the vial.
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Right. And a blank between injections settles the carryover argument before it starts.
Gave the same trace to two people I trust and got two integrations about a point apart. That was the most educational afternoon I have had here.
Retention time shifted 0.4 minutes and I assumed the worst. It was the column temperature.
a shoulder is not an impurity until you can resolve it
I would not blame the sample yet. Everything you have described is consistent with the column rather than the vial.
Can you post the trace with the axes labelled?
Chased a ghost peak for three weeks. It was the plumbing. It is always the plumbing.
- 1reproducibility beats resolution if you only get one of them13 comments in this branch · started by u/mateusz_mensah